Searching: http://spark.kufu.no/fhir/_snapshot?id=8b0b570f-e741-4336-81a6-b9b88f34ce30&start=0
From RowNum: 0
id: 8b0b570f-e741-4336-81a6-b9b88f34ce30 (excluded)
start: 0
First Link: http://spark.kufu.no/fhir/_snapshot?id=8b0b570f-e741-4336-81a6-b9b88f34ce30&start=0
Last Link: http://spark.kufu.no/fhir/_snapshot?id=8b0b570f-e741-4336-81a6-b9b88f34ce30&start=0
Type: Searchset, 18 of 18
PlanDefinition/KDN5/_history/1 Modified: 5/28/2019 2:48:41 PM +02:00

National Comprehensive Cancer Network

Chemotherapy Order Template

Kidney Cancer

Gemcitabine/CARBOplatin

KDN5

INDICATION:

Metastatic or Relapsed – Collecting Duct/Medullary Subtypes

REFERENCES:

  1. NCCN Guidelines® for Kidney Cancer. V.3.2015.
  2. Oudard S, et al. J Urol. 2007;177(5):1698-702. a

NCCN SUPPORTIVE CARE:

  1. Emetic Risk:
    Day 1 Moderate
    Day 8 Low
  2. Fever Neutropenia Risk:
    Refer to NCCN Guidelines for Myeloid Growth Factors. V.2.2014

CHEMOTHERAPY REGIMEN

21-day cycle for 6 cycles

PlanDefinition/chlamydia-screening-intervention/_history/1 Modified: 5/28/2019 2:48:40 PM +02:00

Id:
PlanDefinition/chlamydia-screening-intervention

Identifier:
value: ChlamydiaScreening_CDS_UsingCommon

Title:
Chalmydia Screening CDS Example Using Common

Status:
draft

Description:
Chlamydia Screening CDS Example Using Common

Topic:
text: Chlamydia Screening

Library:
reference: Library/example

Actions

Step:
title: Patient has not had chlamydia screening within the recommended timeframe...
condition:
type: applicability
expression: NoScreening

PlanDefinition/example-cardiology-os/_history/1 Modified: 5/28/2019 2:48:41 PM +02:00

Generated Narrative with Details

id: example-cardiology-os

contained: , , , , , , , , , , , ,

url: http://va.gov/kas/orderset/B5-Cardiology-ChestPainCAD-OS

identifier: bb7ccea6-9744-4743-854a-bcffd87191f6 (OFFICIAL), CLIN0004AG, KP-914

version: 0.1

name: ChestPainCoronaryArteryDiseaseOrderSetKNART

title: Chest Pain (CP) - Coronary Artery Disease (CAD) Order Set KNART

type: Order Set (Details : {http://terminology.hl7.org/CodeSystem/plan-definition-type code 'order-set' = 'Order Set', given as 'Order Set'})

status: active

date: 29/08/2017

publisher: Department of Veterans Affairs

description: The Cardiology chest pain (CP) and coronary artery disease (CAD) group of KNARTs are intended to assist primary care providers in the management of adult patients with stable chest pain (with or without known CAD); aid in determining when a cardiology consultation is appropriate; provide guidance for initial noninvasive diagnostic orders (stress testing) and provide a structured documentation template for the process. Stable patients with cardiac chest pain require risk stratification, office-based workup, initiation of disease-specific medications, and subspecialty referral to a cardiologist.

useContext:

usage: The Cardiology chest pain (CP) and coronary artery disease (CAD) group of KNARTs are intended to assist primary care providers in the management of adult patients with stable chest pain (with or without known CAD); aid in determining when a cardiology consultation is appropriate; provide guidance for initial noninvasive diagnostic orders (stress testing) and provide a structured documentation template for the process. Stable patients with cardiac chest pain require risk stratification, office-based workup, initiation of disease-specific medications, and subspecialty referral to a cardiologist. This context excludes emergent patients (new/ongoing/unstable pattern CP). Included are those patients with stable CP with or without known CAD, to be considered for evaluation by cardiology.

copyright: © Copyright Cognitive Medical Systems, Inc. 9444 Waples Street Suite 300 San Diego, CA 92121

author: , ,

relatedArtifact: , , , , , , , , , , ,

library: #cardiology-chestPain-logic

action

Actions

-
*
*
PlanDefinition/exclusive-breastfeeding-intervention-01/_history/1 Modified: 5/28/2019 2:48:41 PM +02:00

Id:
PlanDefinition/exclusive-breastfeeding-intervention-01

Identifier:
value: exclusive-breastfeeding-intervention-01

Title:
Exclusive Breastfeeding Intervention-01

Status:
active

Description:
Exclusive breastfeeding intervention intended to improve outcomes for exclusive breastmilk feeding of newborns by ensuring that an appropriate breastfeeding readiness assessment order is created if necessary.

Topic:
text: Exclusive Breastfeeding

Library:
reference: Library/library-exclusive-breastfeeding-cds-logic

Actions

Step:
title: Mother should be administered a breastfeeding readiness assessment.
condition:
type: applicability
expression: Should Create Assessment Order
Step:
title: Create the breastfeeding readiness assessment order.
text: Administer a breastfeeding readiness assessment.
Step:
title: Notify the provider to sign the order.
text: A Breastfeeding Readiness Assessment is recommended, please authorize or reject the order.

PlanDefinition/exclusive-breastfeeding-intervention-02/_history/1 Modified: 5/28/2019 2:48:41 PM +02:00

Id:
PlanDefinition/exclusive-breastfeeding-intervention-02

Identifier:
value: exclusive-breastfeeding-intervention-02

Title:
Exclusive Breastfeeding Intervention-02

Status:
active

Description:
Exclusive breastfeeding intervention intended to improve outcomes for exclusive breastmilk feeding of newborns by notifying the provider to sign the breastmilk feeding readiness assessment order, if necessary.

Topic:
text: Exclusive Breastfeeding

Library:
reference: Library/library-exclusive-breastfeeding-cds-logic

Actions

Step:
title: Mother should be administered a breastfeeding readiness assessment.
condition:
type: applicability
expression: Should Notify Provider to Sign Assessment Order
Step:
title: Notify the provider to sign the order.
text: A Breastfeeding Readiness Assessment is recommended, please authorize or reject the order.

PlanDefinition/exclusive-breastfeeding-intervention-03/_history/1 Modified: 5/28/2019 2:48:41 PM +02:00

Id:
PlanDefinition/exclusive-breastfeeding-intervention-03

Identifier:
value: exclusive-breastfeeding-intervention-03

Title:
Exclusive Breastfeeding Intervention-03

Status:
active

Description:
Exclusive breastfeeding intervention intended to improve outcomes for exclusive breastmilk feeding of newborns by notifying the charge and/or bedside nurse to perform the breastfeeding readiness assessment.

Topic:
text: Exclusive Breastfeeding

Library:
reference: Library/library-exclusive-breastfeeding-cds-logic

Actions

Step:
title: Mother should be administered a breastfeeding readiness assessment.
condition:
type: applicability
expression: Should Notify Nurse to Perform Assessment
Step:
title: Notify the charge nurse to perform the assessment.
text: A Breastfeeding Readiness Assessment is recommended, please administer the assessment.
Step:
title: Notify the bedside nurse to perform the assessment.
text: A Breastfeeding Readiness Assessment is recommended, please administer the assessment.

PlanDefinition/exclusive-breastfeeding-intervention-04/_history/1 Modified: 5/28/2019 2:48:41 PM +02:00

Id:
PlanDefinition/exclusive-breastfeeding-intervention-04

Identifier:
value: exclusive-breastfeeding-intervention-04

Title:
Exclusive Breastfeeding Intervention-04

Status:
active

Description:
Exclusive breastfeeding intervention intended to improve outcomes for exclusive breastmilk feeding of newborns by creating a lactation consult for the mother if appropriate.

Topic:
text: Exclusive Breastfeeding

Library:
reference: Library/library-exclusive-breastfeeding-cds-logic

Actions

Step:
title: Mother should be referred to a lactation specialist for consultation.
condition:
type: applicability
expression: Should Create Lactation Consult
Step:
title: Create a lactation consult request.
text: Create a lactation consult request

PlanDefinition/low-suicide-risk-order-set/_history/1 Modified: 5/28/2019 2:48:40 PM +02:00

Id:
PlanDefinition/low-suicide-risk-order-set

Identifier:
value: mmi:low-suicide-risk-order-set

Title:
Low Suicide Risk Order Set

Status:
draft

Description:
Orders to be applied to a patient characterized as low suicide risk.

Purpose:
This order set helps ensure consistent application of appropriate orders for the care of low suicide risk patients.

Usage:
This order set should be applied after assessing a patient for suicide risk, when the findings of that assessment indicate the patient has low suicide risk.

Context:

system: http://terminology.hl7.org/CodeSystem/usage-context-type

code: age

value:
system: https://meshb.nlm.nih.gov
code: D000328
display: Adult

Context:

system: http://terminology.hl7.org/CodeSystem/usage-context-type

code: focus

value:
system: http://snomed.info/sct
code: 87512008
display: Mild major depression

Context:

system: http://terminology.hl7.org/CodeSystem/usage-context-type

code: focus

value:
system: http://snomed.info/sct
code: 40379007
display: Major depression, recurrent, mild

Context:

system: http://terminology.hl7.org/CodeSystem/usage-context-type

code: focus

value:
system: http://snomed.info/sct
code: 394687007
display: Low suicide risk

Context:

system: http://terminology.hl7.org/CodeSystem/usage-context-type

code: focus

value:
system: http://snomed.info/sct
code: 225337009
display: Suicide risk assessment

Context:

system: http://terminology.hl7.org/CodeSystem/usage-context-type

code: user

value:
system: http://snomed.info/sct
code: 309343006
display: Physician

Context:

system: http://terminology.hl7.org/CodeSystem/usage-context-type

code: venue

value:
system: http://snomed.info/sct
code: 440655000
display: Outpatient environment

Topic:
text: Suicide risk assessment

Contributor:
author:
Motive Medical Intelligence

Library:
reference: Library/suiciderisk-orderset-logic
display: SuicideRiskLogic

Actions

Step:
title: Suicide Risk Assessment and Outpatient Management
Step:
title: Consults and Referrals
Step:
text: Refer to outpatient mental health program for evaluation and treatment of mental health conditions now
condition:
reference:
#referralToMentalHealthCare
description: refer to primary care mental-health integrated care program for evaluation and treatment of mental health conditions now
category: referral
Step:
title: Medications
Step:
title: First-Line Antidepressants
Step:
title: Selective Serotonin Reuptake Inhibitors (Choose a mazimum of one or document reasons for exception)
Step:
text: citalopram 20 mg tablet 1 tablet oral 1 time daily now (30 table; 3 refills)
condition:
reference:
#citalopramPrescription
category: drug
Step:
text: escitalopram 10 mg tablet 1 tablet oral 1 time daily now (30 tablet; 3 refills)
Step:
text: fluoxetine 20 mg capsule 1 capsule oral 1 time daily now (30 tablet; 3 refills)
Step:
text: paroxetine 20 mg tablet 1 tablet oral 1 time daily now (30 tablet; 3 refills)
Step:
text: sertraline 50 mg tablet 1 tablet oral 1 time daily now (30 tablet; 3 refills)
Step:
text: Dopamine Norepinephrine Reuptake Inhibitors (Choose a maximum of one or document reasons for exception)
Step:
text: Serotonin Norepinephrine Reuptake Inhibitors (Choose a maximum of one or doument reasons for exception)
Step:
text: Norepinephrine-Serotonin Modulators (Choose a maximum of one or document reasons for exception)

PlanDefinition/opioidcds-04/_history/1 Modified: 5/28/2019 2:48:41 PM +02:00

Generated Narrative with Details

id: opioidcds-04

url: http://hl7.org/fhir/ig/opioid-cds/PlanDefinition/opioidcds-04

identifier: cdc-opioid-guidance (OFFICIAL)

version: 0.1.0

name: cdc-opioid-04

title: CDC Opioid Prescribing Guideline Recommendation #4

type: ECA Rule (Details : {http://terminology.hl7.org/CodeSystem/plan-definition-type code 'eca-rule' = 'ECA Rule', given as 'ECA Rule'})

status: draft

date: 19/03/2018

publisher: Centers for Disease Control and Prevention (CDC)

description: When starting opioid therapy for chronic pain, clinicians should prescribe immediate-release opioids instead of extended-release/long-acting (ER/LA) opioids.

useContext: ,

jurisdiction: United States of America (Details : {urn:iso:std:iso:3166 code 'US' = 'United States of America', given as 'United States of America'})

purpose: CDC’s Guideline for Prescribing Opioids for Chronic Pain is intended to improve communication between providers and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder and overdose. The Guideline is not intended for patients who are in active cancer treatment, palliative care, or end-of-life care.

usage: Providers should use caution when prescribing extended-release/long-acting (ER/LA) opioids as they carry a higher risk and negligible benefit compared to immediate-release opioids.

copyright: © CDC 2016+.

topic: Opioid Prescribing (Details )

author: , , ,

relatedArtifact: ,

library: Library/opioidcds-recommendation-04

action

title: Extended-release opioid prescription triggered.

description: Checking if the trigger prescription meets the inclusion criteria for recommendation #4 workflow.

documentation:

trigger:

Conditions

- Kind Expression
* applicability

groupingBehavior: visual-group

selectionBehavior: exactly-one

dynamicValue

path: action.title

expression:

dynamicValue

path: action.description

expression:

dynamicValue

path: activity.extension

expression:

Actions

-
*
*
*
PlanDefinition/opioidcds-05/_history/1 Modified: 5/28/2019 2:48:42 PM +02:00

Generated Narrative with Details

id: opioidcds-05

url: http://hl7.org/fhir/ig/opioid-cds/PlanDefinition/opioidcds-05

identifier: cdc-opioid-guidance (OFFICIAL)

version: 0.1.0

name: cdc-opioid-05

title: CDC Opioid Prescribing Guideline Recommendation #5

type: ECA Rule (Details : {http://terminology.hl7.org/CodeSystem/plan-definition-type code 'eca-rule' = 'ECA Rule', given as 'ECA Rule'})

status: draft

date: 23/04/2017

publisher: Centers for Disease Control and Prevention (CDC)

description: When opioids are started, providers should prescribe the lowest effective dosage.

useContext: ,

jurisdiction: United States of America (Details : {urn:iso:std:iso:3166 code 'US' = 'United States of America', given as 'United States of America'})

purpose: CDC’s Guideline for Prescribing Opioids for Chronic Pain is intended to improve communication between providers and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder and overdose. The Guideline is not intended for patients who are in active cancer treatment, palliative care, or end-of-life care.

usage: Providers should use caution when prescribing opioids at any dosage, should carefully reassess evidence of individual benefits and risks when considering increasing dosage to ≥50 morphine milligram equivalents (MME)/day, and should avoid increasing dosage to ≥90 MME/day or carefully justify a decision to titrate dosage to >90 MME/day

copyright: © CDC 2016+.

topic: Opioid Prescribing (Details )

author: , , ,

relatedArtifact: ,

library: Library/opioidcds-recommendation-05

action

title: High risk for opioid overdose.

description: Total morphine milligram equivalent (MME) exceeds recommended amount. Taper to less than 50.

documentation:

trigger:

Conditions

- Kind Expression
* applicability

groupingBehavior: visual-group

selectionBehavior: exactly-one

dynamicValue

path: action.title

expression:

dynamicValue

path: action.description

expression:

dynamicValue

path: activity.extension

expression:

Actions

-
*
*
*
*
PlanDefinition/opioidcds-07/_history/1 Modified: 5/28/2019 2:48:42 PM +02:00

Generated Narrative with Details

id: opioidcds-07

url: http://hl7.org/fhir/ig/opioid-cds/PlanDefinition/opioidcds-07

identifier: cdc-opioid-guidance (OFFICIAL)

version: 0.1.0

name: cdc-opioid-07

title: CDC Opioid Prescribing Guideline Recommendation #7

type: ECA Rule (Details : {http://terminology.hl7.org/CodeSystem/plan-definition-type code 'eca-rule' = 'ECA Rule', given as 'ECA Rule'})

status: draft

date: 19/03/2018

publisher: Centers for Disease Control and Prevention (CDC)

description: Clinicians should evaluate benefits and harms with patients within 1 to 4 weeks of starting opioid therapy for chronic pain or of dose escalation. Clinicians should evaluate benefits and harms of continued therapy with patients every 3 months or more frequently.

useContext: ,

jurisdiction: United States of America (Details : {urn:iso:std:iso:3166 code 'US' = 'United States of America', given as 'United States of America'})

purpose: CDC’s Guideline for Prescribing Opioids for Chronic Pain is intended to improve communication between providers and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder and overdose. The Guideline is not intended for patients who are in active cancer treatment, palliative care, or end-of-life care.

usage: If benefits do not outweigh harms of continued opioid therapy, clinicians should optimize other therapies and work with patients to taper opioids to lower dosages or to taper and discontinue opioids.

copyright: © CDC 2016+.

topic: Opioid Prescribing (Details )

author: , , ,

relatedArtifact: ,

library: Library/opioidcds-recommendation-07

action

title: Existing patient should be evaluated for risk of continued opioid therapy.

description: Checking if the trigger prescription meets the inclusion criteria for recommendation #7 workflow.

documentation:

trigger:

Conditions

- Kind Expression
* applicability

groupingBehavior: visual-group

selectionBehavior: exactly-one

dynamicValue

path: action.title

expression:

dynamicValue

path: action.description

expression:

dynamicValue

path: action.extension

expression:

Actions

-
*
*
*
PlanDefinition/opioidcds-08/_history/1 Modified: 5/28/2019 2:48:42 PM +02:00

Generated Narrative with Details

id: opioidcds-08

url: http://hl7.org/fhir/ig/opioid-cds/PlanDefinition/opioidcds-08

identifier: cdc-opioid-guidance (OFFICIAL)

version: 0.1.0

name: cdc-opioid-08

title: CDC Opioid Prescribing Guideline Recommendation #8

type: ECA Rule (Details : {http://terminology.hl7.org/CodeSystem/plan-definition-type code 'eca-rule' = 'ECA Rule', given as 'ECA Rule'})

status: draft

date: 19/03/2018

publisher: Centers for Disease Control and Prevention (CDC)

description: Clinicians should incorporate into the management plan strategies to mitigate risk, including considering offering naloxone when factors that increase risk for opioid overdose, such as history of overdose, history of substance use disorder, higher opioid dosages (≥50 MME/day), or concurrent benzodiazepine use, are present.

useContext: ,

jurisdiction: United States of America (Details : {urn:iso:std:iso:3166 code 'US' = 'United States of America', given as 'United States of America'})

purpose: CDC’s Guideline for Prescribing Opioids for Chronic Pain is intended to improve communication between providers and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder and overdose. The Guideline is not intended for patients who are in active cancer treatment, palliative care, or end-of-life care.

usage: Before starting and periodically during continuation of opioid therapy, clinicians should evaluate risk factors for opioid-related harms.

copyright: © CDC 2016+.

topic: Opioid Prescribing (Details )

author: , , ,

relatedArtifact: ,

library: Library/opioidcds-recommendation-08

action

title: Existing patient exhibits risk factors for opioid-related harms.

description: Checking if the trigger prescription meets the inclusion criteria for recommendation #8 workflow.

documentation:

trigger:

Conditions

- Kind Expression
* applicability

groupingBehavior: visual-group

selectionBehavior: exactly-one

dynamicValue

path: action.description

expression:

dynamicValue

path: action.title

expression:

dynamicValue

path: action.extension

expression:

Actions

-
*
*
*
PlanDefinition/opioidcds-10/_history/1 Modified: 5/28/2019 2:48:42 PM +02:00

Generated Narrative with Details

id: opioidcds-10

url: http://hl7.org/fhir/ig/opioid-cds/PlanDefinition/opioidcds-10

identifier: cdc-opioid-guidance (OFFICIAL)

version: 0.1.0

name: cdc-opioid-10

title: CDC Opioid Prescribing Guideline Recommendation #10

type: ECA Rule (Details : {http://terminology.hl7.org/CodeSystem/plan-definition-type code 'eca-rule' = 'ECA Rule', given as 'ECA Rule'})

status: draft

date: 23/04/2017

publisher: Centers for Disease Control and Prevention (CDC)

description: When prescribing opioids for chronic pain, providers should use urine drug testing before starting opioid therapy and consider urine drug testing at least annually to assess for prescribed medications as well as other controlled prescription drugs and illicit drugs.

useContext: ,

jurisdiction: United States of America (Details : {urn:iso:std:iso:3166 code 'US' = 'United States of America', given as 'United States of America'})

purpose: CDC’s Guideline for Prescribing Opioids for Chronic Pain is intended to improve communication between providers and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder and overdose. The Guideline is not intended for patients who are in active cancer treatment, palliative care, or end-of-life care.

usage: Providers should be aware if patients are taking other prescription drugs or illicit drugs that might increase their risk of an overdose.

copyright: © CDC 2016+.

topic: Opioid Prescribing (Details )

author: , , ,

relatedArtifact:

library: Library/opioidcds-recommendation-10

action

title: Annual Urine Screening Check

description: Patient has not had a urine screening in the past 12 months

documentation:

trigger:

Conditions

- Kind Expression
* applicability

DynamicValues

- Path Expression
* activity.extension

Actions

-
*
*

action

title: Positive Urine Screening Check

description: Patient has a urine screening testing positive for either unprescribed opioids or illicit drugs in the past 12 months

documentation:

Conditions

- Kind Expression
* applicability

Actions

-
*
*
*
PlanDefinition/opioidcds-11/_history/1 Modified: 5/28/2019 2:48:42 PM +02:00

Generated Narrative with Details

id: opioidcds-11

url: http://hl7.org/fhir/ig/opioid-cds/PlanDefinition/opioidcds-11

identifier: cdc-opioid-guidance (OFFICIAL)

version: 0.1.0

name: cdc-opioid-11

title: CDC Opioid Prescribing Guideline Recommendation #11

type: ECA Rule (Details : {http://terminology.hl7.org/CodeSystem/plan-definition-type code 'eca-rule' = 'ECA Rule', given as 'ECA Rule'})

status: draft

date: 19/03/2018

publisher: Centers for Disease Control and Prevention (CDC)

description: Concurrently prescribing opioid medications with benzodiazepines increases the risk of harm for the patient.

useContext: ,

jurisdiction: United States of America (Details : {urn:iso:std:iso:3166 code 'US' = 'United States of America', given as 'United States of America'})

purpose: CDC’s Guideline for Prescribing Opioids for Chronic Pain is intended to improve communication between providers and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder and overdose. The Guideline is not intended for patients who are in active cancer treatment, palliative care, or end-of-life care.

usage: Clinicians should avoid prescribing opioid pain medication and benzodiazepines concurrently whenever possible.

copyright: © CDC 2016+.

topic: Opioid Prescribing (Details )

author: , , ,

relatedArtifact: ,

library: Library/opioidcds-recommendation-11

action

title: Existing patient has concurrent opioid and benzodiazepine prescriptions.

description: Checking if the trigger prescription meets the inclusion criteria for recommendation #11 workflow.

documentation:

trigger:

Conditions

- Kind Expression
* applicability

groupingBehavior: visual-group

selectionBehavior: exactly-one

dynamicValue

path: action.description

expression:

dynamicValue

path: action.title

expression:

dynamicValue

path: action.extension

expression:

Actions

-
*
*
*
PlanDefinition/options-example/_history/1 Modified: 5/28/2019 2:48:42 PM +02:00

[Put rendering here]
PlanDefinition/protocol-example/_history/1 Modified: 5/28/2019 2:48:42 PM +02:00

id: example,

identifier: , system: http://acme.org, value: example-1,

title: Obesity Assessment Protocol,

status: draft,

type: condition,

purpose: Example of A medical algorithm for assessment and treatment of overweight and obesity,

author: , display: National Heart, Lung, and Blood Institute http://www.nhlbi.nih.gov/health-pro/guidelines/current/obesity-guidelines/e_textbook/txgd/algorthm/algorthm.htm,

step: , name: Measure BMI, description: Measure, Weight, Height, Waist, Circumference; Calculate BMI Weight must be measured so that the BMI can be calculated. Most charts are based on weights obtained with the patient wearing undergarments and no shoes. BMI can be manually calculated (kg/[height in meters]2), but is more easily obtained from a nomogram. Waist circumference is important because evidence suggests that abdominal fat is a particularly strong determinant of cardiovascular risk in those with a BMI of 25 to 34.9 kg/m2. Increased waist circumference can also be a marker of increased risk even in persons of normal weight. The technique for measuring waist circumference is described in the text. A nutrition assessment will also help to assess the diet and physical activity habits of overweight patients, precondition: , union: , description: The practitioner must seek to determine whether the patient has ever been overweight. While a technical definition is provided, a simple question such as 'Have you ever been overweight?' will accomplish the same goal. Questions directed towards weight history, dietary habits, physical activities, and medications may provide useful information about the origins of obesity in particular patients., condition: , type: , coding: , system: http://acme.org, code: 1234, display: Obesity, valueBoolean: true, union: , description: BMI Measured in Past 2 Years For those who have not been overweight, a 2 year interval is appropriate for the reassessment of BMI. While this time span is not evidence-based, it is believed to be a reasonable compromise between the need to identify weight gain at an early stage and the need to limit the time, effort, and cost of repeated measurements., condition: , type: , text: BMI in last 2 years, valueBoolean: false, activity: , detail: , category: procedure, code: , coding: , system: http://loinc.org, code: 39156-5, display: Body mass index (BMI) [Ratio], performer: , display: Nurse Ratched, description: Extra information on activity ,

PlanDefinition/zika-virus-intervention-initial/_history/1 Modified: 5/28/2019 2:48:42 PM +02:00

Id:
PlanDefinition/zika-virus-intervention-initial

Identifier:
value: zika-virus-intervention

Title:
Example Zika Virus Intervention

Status:
active

Description:
Zika Virus Management intervention describing the CDC Guidelines for Zika Virus Reporting and Management.

Topic:
text: Zika Virus Management

Library:
reference: Library/zika-virus-intervention-logic

Actions

Step:
title: Zika Virus Assessment
condition:
type: applicability
expression: Is Patient Pregnant
Step:
condition:
type: applicability
expression: Should Administer Zika Virus Exposure Assessment
condition:
reference:
#administer-zika-virus-exposure-assessment
description: Administer Zika Virus Exposure Assessment
category: procedure
Step:
condition:
type: applicability
expression: Should Order Serum + Urine rRT-PCR Test
condition:
reference:
ActivityDefinition/order-serum-urine-rrt-pcr-test
Step:
condition:
type: applicability
expression: Should Order Serum Zika Virus IgM + Dengue Virus IgM
condition:
reference:
#order-serum-zika-dengue-virus-igm
description: Order Serum Zika and Dengue Virus IgM
related:
type: documentation
display: Explanation of diagnostic tests for Zika virus and which to use based on the patients clinical and exposure history.
category: diagnostic
Step:
condition:
type: applicability
expression: Should Consider IgM Antibody Testing
condition:
reference:
ActivityDefinition/consider-igm-antibody-testing
Step:
condition:
type: applicability
expression: Should Provide Mosquito Prevention and Contraception Advice
Step:
condition:
reference:
#provide-mosquito-prevention-advice
description: Provide mosquito prevention advice
related:
type: documentation
display: Advice for patients about how to avoid Mosquito bites.
related:
type: documentation
display: Advice for patients about which mosquito repellents are effective and safe to use in pregnancy. [DEET, IF3535 and Picardin are safe during]
category: communication
Step:
condition:
reference:
ActivityDefinition/provide-contraception-advice

PlanDefinition/zika-virus-intervention/_history/1 Modified: 5/28/2019 2:48:42 PM +02:00

Id:
PlanDefinition/zika-virus-intervention

Identifier:
value: zika-virus-intervention

Title:
Example Zika Virus Intervention

Status:
active

Description:
Zika Virus Management intervention describing the CDC Guidelines for Zika Virus Reporting and Management.

Topic:
text: Zika Virus Management

Library:
reference: Library/zika-virus-intervention-logic

Actions

Step:
title: Zika Virus Assessment
condition:
type: applicability
expression: Is Patient Pregnant
Step:
condition:
type: applicability
expression: Should Administer Zika Virus Exposure Assessment
condition:
reference:
#administer-zika-virus-exposure-assessment
description: Administer Zika Virus Exposure Assessment
category: procedure
Step:
condition:
type: applicability
expression: Should Order Serum + Urine rRT-PCR Test
condition:
reference:
ActivityDefinition/order-serum-urine-rrt-pcr-test
Step:
condition:
type: applicability
expression: Should Order Serum Zika Virus IgM + Dengue Virus IgM
condition:
reference:
#order-serum-zika-dengue-virus-igm
description: Order Serum Zika and Dengue Virus IgM
related:
type: documentation
display: Explanation of diagnostic tests for Zika virus and which to use based on the patients clinical and exposure history.
category: diagnostic
Step:
condition:
type: applicability
expression: Should Consider IgM Antibody Testing
condition:
reference:
ActivityDefinition/consider-igm-antibody-testing
Step:
condition:
type: applicability
expression: Should Provide Mosquito Prevention and Contraception Advice
Step:
condition:
reference:
#provide-mosquito-prevention-advice
description: Provide mosquito prevention advice
related:
type: documentation
display: Advice for patients about how to avoid Mosquito bites.
related:
type: documentation
display: Advice for patients about which mosquito repellents are effective and safe to use in pregnancy. [DEET, IF3535 and Picardin are safe during]
category: communication
Step:
condition:
reference:
ActivityDefinition/provide-contraception-advice